During the past decade, Allina Health conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allina Health" #1 sponsor was "Allina Health System" with 5 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Duke University" with 2 trials sponsored, "Adrian Hernandez" with 1 trials sponsored and "CytomX Therapeutics" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allina Health" #1 collaborator was "Patient-Centered Outcomes Research Institute" with 3 trials as a collaborator, "Allina Health System" with 2 trials as a collaborator, "Agnes Marshall Walker Foundation" with 1 trials as a collaborator, "Chicago Area Patient-Centered Outcomes Research Network (CAPriCORN)" with 1 trials as a collaborator and "Greater Plains Collaborative Clinical Data Research Network" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Allina Health" are "Quality of Life" (2 trials), "Stress" (2 trials), "Acute Myocardial Infarction" (1 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Allina Health" in a lesser frequency.

Most popular intervention types in "Allina Health" are "Drug" (9 trials), "Other" (5 trials), "Behavioral" (4 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Nivolumab" (2 trials), "Placebo oral tablet" (2 trials), "Atorvastatin 40 Mg Oral Tablet" (1 trials) and "BMS-936558" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allina Health" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Allina Health". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Allina Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allina Health, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".